Difficulty: Medium
Average Score: 66%
Practice
What is the significance of HER2 positivity in breast cancer?
Correct answer
A
Rationale
The correct answer is A) Indicates aggressive tumor behavior and potential resistance to certain treatments.
HER2 (Human Epidermal Growth Factor Receptor 2) is a protein that can promote the growth of cancer cells. In breast cancer, HER2 positivity indicates that the cancer cells overexpress this protein, leading to more aggressive tumor behavior. This overexpression is associated with a higher risk of disease recurrence and poorer prognosis.
Option B) Signifies slower tumor growth is incorrect because HER2 positivity is actually associated with faster tumor growth due to the overexpression of growth-promoting proteins.
Option C) Indicates sensitivity to hormone therapy is incorrect because HER2-positive breast cancers are not typically sensitive to hormone therapy. They may require targeted therapies that specifically address the HER2 protein.
Option D) Denotes a benign tumor is incorrect because HER2 positivity is not associated with benign tumors but rather with more aggressive and malignant breast cancers.
Educationally, understanding the significance of HER2 positivity in breast cancer is crucial for healthcare professionals involved in the treatment and management of breast cancer patients. It helps in determining the appropriate treatment strategies, including targeted therapies like HER2 inhibitors, to improve patient outcomes. It also underscores the importance of molecular profiling in guiding personalized cancer treatment approaches.
HER2 (Human Epidermal Growth Factor Receptor 2) is a protein that can promote the growth of cancer cells. In breast cancer, HER2 positivity indicates that the cancer cells overexpress this protein, leading to more aggressive tumor behavior. This overexpression is associated with a higher risk of disease recurrence and poorer prognosis.
Option B) Signifies slower tumor growth is incorrect because HER2 positivity is actually associated with faster tumor growth due to the overexpression of growth-promoting proteins.
Option C) Indicates sensitivity to hormone therapy is incorrect because HER2-positive breast cancers are not typically sensitive to hormone therapy. They may require targeted therapies that specifically address the HER2 protein.
Option D) Denotes a benign tumor is incorrect because HER2 positivity is not associated with benign tumors but rather with more aggressive and malignant breast cancers.
Educationally, understanding the significance of HER2 positivity in breast cancer is crucial for healthcare professionals involved in the treatment and management of breast cancer patients. It helps in determining the appropriate treatment strategies, including targeted therapies like HER2 inhibitors, to improve patient outcomes. It also underscores the importance of molecular profiling in guiding personalized cancer treatment approaches.